Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Rapid Dose Therapeutics Corp C.DOSE

Alternate Symbol(s):  RDTCF

Rapid Dose Therapeutics Corp. is a Canadian biotechnology company. It provides disruptive drug delivery technologies designed to improve patient outcomes. Its flagship product, QuickStrip, is a thin, orally dissolvable film that can be infused with an infinite list of active ingredients, including nutraceuticals, pharmaceuticals, and vaccines, that are delivered quickly into the bloodstream, resulting in rapid onset of the active ingredient. It has one operating segment comprising production, distribution, research, and the provision of technical services for the delivery of oral thin film strips containing active ingredients. It offers over-the-counter and pharmaceutical drug delivery solutions. Its QuickStrip Energy delivers energizing caffeine. Its QuickStrip B12 delivers vitamin B12 to the system, assisting with metabolism and physical energy. Its QuickStrip Sleep delivers melatonin to the system, inducing natural and healthy sleep. QuickStrip Lidocaine is its dental product.


CSE:DOSE - Post by User

Post by lscfaon Jan 12, 2023 11:29am
164 Views
Post# 35218513

Sue the auditors?

Sue the auditors?

VANCOUVER, British Columbia, Jan. 12, 2023 (GLOBE NEWSWIRE) -- PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) (“PlantX” or the “Company”), the digital face of the plant-based community, operating a one-stop shop for plant-based products, today announced retaining a law firm to review and assess legal options against auditors.

PlantX has identified concerns with the delay, preparation, and issuance of the restatement of its fiscal 2021 financial statements and the audit of its fiscal 2022 financial statements. PlantX has retained Kushneryk Morgan LLP to review and assess legal options, including seeking financial recovery, to address the harm caused by the delay, preparation, and issuance of those materials. PlantX will take appropriate legal action against those who are responsible.

Kushneryk Morgan LLP is a boutique law firm in Toronto, Ontario with expertise in corporate commercial litigation and arbitration, securities and other regulatory enforcement matters, special situations and crises, and internal investigations and risk management.

<< Previous
Bullboard Posts
Next >>